BRPI0313647A2 - inhalation compositions - Google Patents
inhalation compositionsInfo
- Publication number
- BRPI0313647A2 BRPI0313647A2 BRPI0313647A BRPI0313647A BRPI0313647A2 BR PI0313647 A2 BRPI0313647 A2 BR PI0313647A2 BR PI0313647 A BRPI0313647 A BR PI0313647A BR PI0313647 A BRPI0313647 A BR PI0313647A BR PI0313647 A2 BRPI0313647 A2 BR PI0313647A2
- Authority
- BR
- Brazil
- Prior art keywords
- microns
- diameter
- less
- lactose particles
- inhalation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Otolaryngology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
"composições inalação". a invenção fornece uma composição de inalação de pó seco compreendendo partículas de medicamento e uma mistura de partículas de lactose com um vmd dentre cerca de 10 e cerca de 120 mícrons e um diâmetro menor do que 250 mícrons, a mistura sendo caracterizada pelo fato de que até 96% em peso das partículas de lactose são menores do que 150 mícrons de diâmetro e onde até 25% em peso das partículas de lactose são menores do que 5 mícrons de diâmetro. as composições fornecem uma dispersão consistente e uniforme, mais precisa quando empregada com, por exemplo, um inalador de pó seco de múltiplas doses. são também descritos métodos para uso da composição da invenção."inhalation compositions". The invention provides a dry powder inhalation composition comprising medicament particles and a mixture of lactose particles with a vmd of from about 10 to about 120 microns and a diameter of less than 250 microns, the mixture being characterized by the fact that Up to 96% by weight of lactose particles are less than 150 microns in diameter and where up to 25% by weight of lactose particles are less than 5 microns in diameter. The compositions provide a consistent and uniform dispersion, most accurate when employed with, for example, a multiple dose dry powder inhaler. Also described are methods for using the composition of the invention.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0219513A GB0219513D0 (en) | 2002-08-21 | 2002-08-21 | Inhalation compositions including coarse carrier |
| PCT/US2003/026385 WO2004017914A2 (en) | 2002-08-21 | 2003-08-21 | Inhalation composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0313647A2 true BRPI0313647A2 (en) | 2019-02-19 |
Family
ID=9942746
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0313647A BRPI0313647A2 (en) | 2002-08-21 | 2003-08-21 | inhalation compositions |
Country Status (8)
| Country | Link |
|---|---|
| BR (1) | BRPI0313647A2 (en) |
| CA (1) | CA2499273C (en) |
| ES (1) | ES2371601T3 (en) |
| GB (1) | GB0219513D0 (en) |
| NO (1) | NO20051461L (en) |
| TN (1) | TNSN05047A1 (en) |
| WO (1) | WO2004017914A2 (en) |
| ZA (1) | ZA200502177B (en) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005102429A1 (en) | 2004-04-21 | 2005-11-03 | Innovata Biomed Limited | Inhaler |
| WO2005104712A2 (en) | 2004-04-23 | 2005-11-10 | Cydex, Inc. | Dpi formulation containing sulfoalkyl ether cyclodextrin |
| GB0409197D0 (en) | 2004-04-24 | 2004-05-26 | Innovata Biomed Ltd | Device |
| KR20070119631A (en) | 2005-02-10 | 2007-12-20 | 글락소 그룹 리미티드 | Processes for making lactose utilizing pre-classification techniques and pharmaceutical formulations formed therefrom |
| US7629331B2 (en) | 2005-10-26 | 2009-12-08 | Cydex Pharmaceuticals, Inc. | Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof |
| GB0605723D0 (en) | 2006-03-23 | 2006-05-03 | 3M Innovative Properties Co | Powder filling processes |
| WO2008134817A1 (en) * | 2007-05-03 | 2008-11-13 | The University Of Sydney | Composite carriers for dry powder inhalation therapy |
| TR201105367A2 (en) * | 2011-06-02 | 2012-12-21 | Bi̇lgi̇ç Mahmut | A dry powder formulation with improved flow properties. |
| TR201205852A2 (en) * | 2011-06-02 | 2012-12-21 | Bi̇lgi̇ç Mahmut | Improved new dry powder formulation. |
| GEP201706672B (en) | 2012-07-05 | 2017-05-25 | Arven Ilac Sanayi Ve Ticaret As | Dry powder inhaler compositions comprising long acting muscorinic antagonists |
| MX354365B (en) | 2012-07-19 | 2018-02-28 | Adamis Pharmaceuticals Corp | Powder feeding apparatus. |
| JP6251667B2 (en) | 2014-06-03 | 2017-12-20 | アサヒカルピスウェルネス株式会社 | Tablet-type immediate release preparation and method for producing the same |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1283036E (en) * | 1998-11-13 | 2008-03-06 | Jagotec Ag | Multidosis dry powder inhaler with powder reservoir |
| CA2354576C (en) * | 1998-12-11 | 2008-10-14 | Pharmachemie B.V. | Pharmaceutical preparation for inhalation of an opioid |
| UA75375C2 (en) | 2000-10-12 | 2006-04-17 | Boehringer Ingelheim Pharma | Method for producing powdery preparations for inhaling |
| WO2002030389A1 (en) | 2000-10-12 | 2002-04-18 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Novel tiotropium-containing inhalation powder |
-
2002
- 2002-08-21 GB GB0219513A patent/GB0219513D0/en not_active Ceased
-
2003
- 2003-08-21 BR BRPI0313647A patent/BRPI0313647A2/en active Search and Examination
- 2003-08-21 WO PCT/US2003/026385 patent/WO2004017914A2/en active Application Filing
- 2003-08-21 CA CA2499273A patent/CA2499273C/en not_active Expired - Fee Related
- 2003-08-21 ES ES03751884T patent/ES2371601T3/en not_active Expired - Lifetime
-
2005
- 2005-02-18 TN TNP2005000047A patent/TNSN05047A1/en unknown
- 2005-03-15 ZA ZA200502177A patent/ZA200502177B/en unknown
- 2005-03-18 NO NO20051461A patent/NO20051461L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004017914A3 (en) | 2004-04-29 |
| TNSN05047A1 (en) | 2007-05-14 |
| ES2371601T3 (en) | 2012-01-05 |
| GB0219513D0 (en) | 2002-10-02 |
| WO2004017914A8 (en) | 2005-07-07 |
| CA2499273A1 (en) | 2004-03-04 |
| NO20051461L (en) | 2005-05-20 |
| WO2004017914A2 (en) | 2004-03-04 |
| CA2499273C (en) | 2011-06-21 |
| ZA200502177B (en) | 2006-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112022024943A2 (en) | EFERVESCENT ORAL COMPOSITION COMPRISING AN ACTIVE INGREDIENT | |
| BR9911351A (en) | Pharmaceutical formulations for aerosols with two or more active substances | |
| TNSN05047A1 (en) | Inhalation composition | |
| BR0303348A (en) | Aerosol formulations for pulmonary drug delivery to produce systemic effect | |
| BR9916865A (en) | Aerosol pharmaceutical composition containing hfa 227 and hfa 134a | |
| BR9811249A (en) | New formulation for inhalation; showing volumetric density, when poured, from 0.20 to 0.38g / ml, process for preparing formulation and using it | |
| BR0110139A (en) | Pharmaceutical formulations for dry powder inhalers | |
| BR112015023922A2 (en) | pharmaceutical composition comprising an ampk activator and a serotonergic agent and methods of using these | |
| BRPI0608791B8 (en) | capsules for inhalers, use of a polymer composition and process for drying inhalation powders | |
| AR054222A1 (en) | PROCEDURE TO PRODUCE A PROTECTED PHARMACEUTICAL FORM BEFORE FRAUDULENT USE | |
| CL2009001560A1 (en) | Nutritional composition for babies comprising a mixture of oligosaccharides composed of n-acetylated oligosaccharides, galactooligosaccharides and sialylated oligosaccharides; And its use. | |
| BR0012351A (en) | Powders consisting of particles with a perfectly smooth surface, for use as vehicles for the preparation of inhalation mixtures with micronized drugs and the method for their preparation | |
| BR9914932A (en) | Process for the manufacture of an isotretinoin composition, micronized isotretinoin composition, unit dosage form for enteral administration and pharmaceutical composition in unit form | |
| ATE271383T1 (en) | POWDER FORMULATION FOR INHALATION | |
| BR9917246A (en) | Advanced pharmaceutical compositions for inhalation powder | |
| BR112012007182A2 (en) | use of desiccant entrained material, metered dose pressurized inhaler dosing valve, metered dose pressurized inhaler closed container system, and method for stabilizing the fine particle mass (mpf) of an inhalation drug formulation | |
| BR0112903A (en) | Electrostatic powder | |
| BR9809865A (en) | Perfume fixer, perfume and base product mixed with it, and perfumed product. | |
| BRPI0313764A2 (en) | method of preparing dry powder inhalation compositions | |
| BRPI0417097A (en) | pre-metered dry powder inhaler for moisture sensitive medicines | |
| BR112022002630A2 (en) | Dry powder pharmaceutical composition suitable for administration by inhalation, dry powder inhaler and method of treating or preventing diseases or conditions | |
| BR9912152A (en) | Pigment materials and their uses in coating compositions | |
| ATE520405T1 (en) | INHALATION COMPOSITION | |
| BR0104688A (en) | Modifying composition of powder impact, dispersion of particles of spray-drying polymer, and polymeric composition | |
| BRPI0614197B8 (en) | pharmaceutically effective composition in a dosage form for peroral administration containing at least one of the active ingredients indomethacin and acemetacin, forms of administration, and use of the composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B12F | Appeal: other appeals | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
| B06F | Objections, documents and/or translations needed after an examination request according art. 34 industrial property law | ||
| B08F | Application fees: dismissal - article 86 of industrial property law |
Free format text: REFERENTE A 15A ANUIDADE |